Insulin-sensitizing agents in women with polycystic ovary syndrome
Authors:
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 86, S28-S29
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndromeHuman Reproduction, 2004
- ThiazolidinedionesNew England Journal of Medicine, 2004
- Effect of the Insulin Sensitizer Pioglitazone on Insulin Resistance, Hyperandrogenism, and Ovulatory Dysfunction in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2004
- Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndromeFertility and Sterility, 2004
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003
- Insulin-Lowering Agents in the Management of Polycystic Ovary SyndromeEndocrine Reviews, 2003
- MetforminDrugs, 2003
- Obesity and the polycystic ovary syndromeInternational Journal of Obesity, 2002
- The Insulin-Related Ovarian Regulatory System in Health and DiseaseEndocrine Reviews, 1999
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995